| IBD | Inflammatory bowel disease |
| UC | Ulcerative colitis |
| CD | Crohn’s disease |
| CRC | Colorectal cancer |
| PSC | Primary sclerosing cholangitis |
| 5-ASA | 5-Aminosalicylates |
| ECCO | European Crohn’s and Colitis Organization |
| AZA | Azathioprine |
| 6-MP | 6-mercaptopurine |
| MTX | Methotrexate |
| anti-TNFα | Infliximab, Adalimumab, Golimumab |
| IFX | Infliximab |
| ADA | Adalimumab |
| GLM | Golimumab |
| VDZ | Vedolizumab |
| UST | Ustekinumab |
| IQR | Interquartile range |
| HR | Hazard ratio |
| CI | Confidence interval |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.